(Reuters) – The advisory committee to European Union’s drug regulator on Friday said it has recommended reducing the interval between the second dose and booster dose of Moderna Inc’s COVID-19 vaccine from six months to three months.
(Reporting by Manojna Maddipatla in Bengaluru; Editing by Hugh Lawson)
